Both in Surgical Instruments
Pulse Biosciences, Inc Common Stock (DE) vs AtriCure
Over the past year PLSE returned +211.1% and ATRC returned +80.0%; their daily moves had a correlation of 0.17.
PLSE +211.1% ATRC +80.0%Growth of $1, one year, split-adjusted
| Metric | PLSE | ATRC |
|---|---|---|
| Price | $52.24 | $61.25 |
| Market cap | $3.73B | $3.12B |
| Today | −5.84% | −1.97% |
| 1 month | +4.8% | +14.3% |
| 6 months | +150.8% | +111.1% |
| Year to date | +280.5% | +54.8% |
| 1 year | +205.3% | +72.8% |
| Revenue growth (YoY) | — | +12.8% |
| Gross margin | 37.1% | 77.2% |
| Net margin | −5681.3% | 5.8% |
| P/E (TTM) | — | 295.3× |
| Price / sales | 3,144.2× | 5.5× |
| Net cash | $101.6M | $106.8M |
| Dividend yield | — | — |
| Volatility (60d) | 64.7% | 37.8% |
| Short % of float | 16.4% | 10.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).